| 0 |
RE-OPENING OF DUCTUS ARTERIOSUS |
1 |
0.2000 |
| 1 |
INSULINOMA |
22 |
0.1243 |
| 2 |
PANCREATIC ISLETS HYPERPLASIA |
2 |
0.0952 |
| 3 |
BREAST MILK SUBSTITUTE INTOLERANCE |
1 |
0.0833 |
| 4 |
PANCREATICOSPLENECTOMY |
1 |
0.0769 |
| 5 |
CNS GERMINOMA |
1 |
0.0625 |
| 6 |
HYPERINSULINAEMIC HYPOGLYCAEMIA |
11 |
0.0495 |
| 7 |
ADENOVIRAL CONJUNCTIVITIS |
1 |
0.0345 |
| 8 |
RENAL FUNCTION TEST |
1 |
0.0323 |
| 9 |
MECONIUM ILEUS |
2 |
0.0303 |
| 10 |
NEONATAL PULMONARY HYPERTENSION |
1 |
0.0263 |
| 11 |
NECROLYTIC MIGRATORY ERYTHEMA |
1 |
0.0256 |
| 12 |
GASTRIC HYPERMOTILITY |
1 |
0.0250 |
| 13 |
PROSTATITIS ESCHERICHIA COLI |
1 |
0.0200 |
| 14 |
PULMONARY ARTERIOPATHY |
1 |
0.0200 |
| 15 |
RIGHT VENTRICULAR HYPERTENSION |
1 |
0.0196 |
| 16 |
HYPERINSULINISM |
2 |
0.0187 |
| 17 |
VIRAL TONSILLITIS |
1 |
0.0179 |
| 18 |
NECROTISING ENTEROCOLITIS NEONATAL |
7 |
0.0172 |
| 19 |
ELECTROCARDIOGRAM U WAVE PRESENT |
1 |
0.0161 |
| 20 |
NECROTISING COLITIS |
20 |
0.0158 |
| 21 |
ACQUIRED HYDROCELE |
1 |
0.0120 |
| 22 |
HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME |
13 |
0.0117 |
| 23 |
BENIGN NEOPLASM OF SPINAL CORD |
1 |
0.0111 |
| 24 |
ACANTHOSIS NIGRICANS |
2 |
0.0108 |
| 25 |
PANCREATECTOMY |
6 |
0.0108 |
| 26 |
HEPATOBLASTOMA |
1 |
0.0103 |
| 27 |
ABNORMAL CLOTTING FACTOR |
2 |
0.0098 |
| 28 |
HYPERAMMONAEMIC CRISIS |
1 |
0.0093 |
| 29 |
RETINOBLASTOMA |
1 |
0.0092 |
| 30 |
GAMMA-GLUTAMYLTRANSFERASE |
1 |
0.0092 |
| 31 |
CONGENITAL MEGACOLON |
1 |
0.0088 |
| 32 |
BENIGN UTERINE NEOPLASM |
1 |
0.0085 |
| 33 |
PULMONARY VEIN STENOSIS |
1 |
0.0085 |
| 34 |
INSULIN AUTOIMMUNE SYNDROME |
3 |
0.0084 |
| 35 |
BLOOD GROWTH HORMONE ABNORMAL |
1 |
0.0082 |
| 36 |
HYPOGLYCAEMIC SEIZURE |
7 |
0.0077 |
| 37 |
FEVER NEONATAL |
1 |
0.0076 |
| 38 |
SOFT TISSUE NEOPLASM |
1 |
0.0076 |
| 39 |
INSULIN C-PEPTIDE INCREASED |
1 |
0.0072 |
| 40 |
HYPEROSMOLAR HYPERGLYCAEMIC STATE |
1 |
0.0071 |
| 41 |
HYPERTRICHOSIS |
13 |
0.0070 |
| 42 |
GASTROENTERITIS ROTAVIRUS |
2 |
0.0065 |
| 43 |
MUCOCUTANEOUS DISORDER |
1 |
0.0063 |
| 44 |
AMINO ACID LEVEL DECREASED |
2 |
0.0059 |
| 45 |
COLON CANCER STAGE I |
1 |
0.0057 |
| 46 |
JEJUNOSTOMY |
1 |
0.0055 |
| 47 |
BLOOD ALKALINE PHOSPHATASE |
1 |
0.0054 |
| 48 |
RICKETS |
1 |
0.0053 |
| 49 |
EXPOSURE TO EXTREME TEMPERATURE |
1 |
0.0052 |
| 50 |
ZINC DEFICIENCY |
1 |
0.0047 |
| 51 |
LAPAROSCOPIC SURGERY |
1 |
0.0046 |
| 52 |
PANCREATIC OPERATION |
1 |
0.0046 |
| 53 |
NEUTROPENIA NEONATAL |
1 |
0.0045 |
| 54 |
LAPAROTOMY |
2 |
0.0044 |
| 55 |
ANAPHYLACTOID SHOCK |
2 |
0.0043 |
| 56 |
PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC |
1 |
0.0042 |
| 57 |
NEUROENDOCRINE CARCINOMA METASTATIC |
1 |
0.0041 |
| 58 |
LEFT VENTRICULAR ENLARGEMENT |
1 |
0.0039 |
| 59 |
OVERGROWTH BACTERIAL |
1 |
0.0037 |
| 60 |
PULMONARY HYPERTENSIVE CRISIS |
1 |
0.0037 |
| 61 |
PERIVENTRICULAR LEUKOMALACIA |
1 |
0.0035 |
| 62 |
CARDIO-RESPIRATORY DISTRESS |
1 |
0.0035 |
| 63 |
SALIVARY GLAND NEOPLASM |
1 |
0.0035 |
| 64 |
AGITATED DEPRESSION |
1 |
0.0035 |
| 65 |
HYPEROSMOLAR STATE |
1 |
0.0035 |
| 66 |
FEBRILE CONVULSION |
4 |
0.0033 |
| 67 |
HYPERINSULINAEMIA |
1 |
0.0033 |
| 68 |
THERAPEUTIC EMBOLISATION |
1 |
0.0032 |
| 69 |
RETROPERITONEAL ABSCESS |
1 |
0.0032 |
| 70 |
BACTERIAL TRANSLOCATION |
1 |
0.0032 |
| 71 |
PSEUDOCYST |
1 |
0.0031 |
| 72 |
HYPOGLYCAEMIA NEONATAL |
5 |
0.0031 |
| 73 |
CENTRAL HYPOTHYROIDISM |
1 |
0.0030 |
| 74 |
BACTERIAL PYELONEPHRITIS |
1 |
0.0030 |
| 75 |
BASAL GANGLIA INFARCTION |
1 |
0.0029 |
| 76 |
GROWTH FAILURE |
1 |
0.0029 |
| 77 |
NEONATAL INFECTION |
1 |
0.0029 |
| 78 |
HEART RATE |
1 |
0.0029 |
| 79 |
TACHYPHYLAXIS |
1 |
0.0029 |
| 80 |
PANCREATIC INSUFFICIENCY |
1 |
0.0028 |
| 81 |
PORTAL VENOUS GAS |
1 |
0.0028 |
| 82 |
OTITIS MEDIA ACUTE |
2 |
0.0027 |
| 83 |
SCAN ABNORMAL |
1 |
0.0027 |
| 84 |
LUNG CYST |
1 |
0.0025 |
| 85 |
TRACHEOMALACIA |
1 |
0.0025 |
| 86 |
HYPOGLYCAEMIC UNCONSCIOUSNESS |
5 |
0.0025 |
| 87 |
UPPER RESPIRATORY TRACT INFLAMMATION |
3 |
0.0025 |
| 88 |
TUMOUR ASSOCIATED FEVER |
1 |
0.0024 |
| 89 |
ATRIAL THROMBOSIS |
5 |
0.0024 |
| 90 |
VOLUME BLOOD DECREASED |
1 |
0.0024 |
| 91 |
DIABETIC HYPEROSMOLAR COMA |
1 |
0.0023 |
| 92 |
PNEUMATOSIS |
1 |
0.0022 |
| 93 |
FEEDING INTOLERANCE |
1 |
0.0022 |
| 94 |
BONE CYST |
2 |
0.0021 |
| 95 |
HYPOGLYCAEMIA |
101 |
0.0021 |
| 96 |
INTRAVENTRICULAR HAEMORRHAGE NEONATAL |
1 |
0.0021 |
| 97 |
BONE MARROW DEPRESSION |
2 |
0.0020 |
| 98 |
PATENT DUCTUS ARTERIOSUS |
8 |
0.0020 |
| 99 |
NEONATAL RESPIRATORY FAILURE |
1 |
0.0020 |
| 100 |
RIGHT ATRIAL DILATATION |
1 |
0.0020 |
| 101 |
NEONATAL DISORDER |
3 |
0.0019 |
| 102 |
FAECAL VOMITING |
1 |
0.0019 |
| 103 |
KETOSIS |
2 |
0.0018 |
| 104 |
RIGHT VENTRICULAR DYSFUNCTION |
2 |
0.0018 |
| 105 |
BLOOD INSULIN INCREASED |
1 |
0.0018 |
| 106 |
NAIL BED BLEEDING |
1 |
0.0018 |
| 107 |
CARDIORENAL SYNDROME |
1 |
0.0017 |
| 108 |
HYPOGLYCAEMIC COMA |
5 |
0.0017 |
| 109 |
MOTOR DEVELOPMENTAL DELAY |
1 |
0.0017 |
| 110 |
NEURODEGENERATIVE DISORDER |
1 |
0.0016 |
| 111 |
HYPERVOLAEMIA |
8 |
0.0016 |
| 112 |
SERUM SICKNESS-LIKE REACTION |
1 |
0.0016 |
| 113 |
OEDEMA GENITAL |
1 |
0.0016 |
| 114 |
PANCREATIC NEUROENDOCRINE TUMOUR |
1 |
0.0016 |
| 115 |
OBSTRUCTION GASTRIC |
2 |
0.0016 |
| 116 |
HIRSUTISM |
2 |
0.0015 |
| 117 |
BRONCHITIS VIRAL |
1 |
0.0015 |
| 118 |
HEAT ILLNESS |
1 |
0.0015 |
| 119 |
CYST RUPTURE |
1 |
0.0015 |
| 120 |
NEUROENDOCRINE CARCINOMA |
1 |
0.0014 |
| 121 |
IMMUNE THROMBOCYTOPENIC PURPURA |
4 |
0.0014 |
| 122 |
DIET REFUSAL |
1 |
0.0014 |
| 123 |
CHOLANGITIS ACUTE |
1 |
0.0013 |
| 124 |
GASTROINTESTINAL SURGERY |
1 |
0.0013 |
| 125 |
ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY |
1 |
0.0013 |
| 126 |
HYPERGLYCAEMIA |
46 |
0.0013 |
| 127 |
POST-TRAUMATIC NECK SYNDROME |
1 |
0.0012 |
| 128 |
KETONURIA |
1 |
0.0012 |
| 129 |
SUPERFICIAL VEIN THROMBOSIS |
1 |
0.0012 |
| 130 |
ADRENAL SUPPRESSION |
1 |
0.0012 |
| 131 |
DEAFNESS BILATERAL |
2 |
0.0012 |
| 132 |
MALIGNANT HYPERTENSION |
1 |
0.0012 |
| 133 |
ABDOMINAL LYMPHADENOPATHY |
1 |
0.0012 |
| 134 |
FOOD REFUSAL |
1 |
0.0011 |
| 135 |
CARDIAC OUTPUT DECREASED |
1 |
0.0011 |
| 136 |
DRUG WITHDRAWAL CONVULSIONS |
2 |
0.0011 |
| 137 |
RIGHT VENTRICULAR HYPERTROPHY |
1 |
0.0011 |
| 138 |
PROTEIN URINE |
1 |
0.0011 |
| 139 |
INTESTINAL INFARCTION |
1 |
0.0011 |
| 140 |
FACIAL ASYMMETRY |
1 |
0.0010 |
| 141 |
GROWTH RETARDATION |
3 |
0.0010 |
| 142 |
HYPERNATRAEMIA |
5 |
0.0010 |
| 143 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
3 |
0.0010 |
| 144 |
VENOUS THROMBOSIS LIMB |
2 |
0.0010 |
| 145 |
OLIGURIA |
6 |
0.0010 |
| 146 |
SUBILEUS |
2 |
0.0010 |
| 147 |
INJECTION SITE HYPERSENSITIVITY |
3 |
0.0010 |
| 148 |
PERTUSSIS |
1 |
0.0010 |
| 149 |
FEEDING DISORDER NEONATAL |
1 |
0.0010 |
| 150 |
HYPOPERFUSION |
1 |
0.0010 |
| 151 |
SYSTOLIC DYSFUNCTION |
1 |
0.0009 |
| 152 |
CUSHINGOID |
3 |
0.0009 |
| 153 |
PORTAL VEIN THROMBOSIS |
3 |
0.0009 |
| 154 |
DRUG EXPOSURE VIA BREAST MILK |
1 |
0.0009 |
| 155 |
PULMONARY HYPERTENSION |
19 |
0.0009 |
| 156 |
CRYPTORCHISM |
1 |
0.0009 |
| 157 |
BLOODY DISCHARGE |
1 |
0.0009 |
| 158 |
THERAPEUTIC PRODUCT EFFECT INCREASED |
1 |
0.0009 |
| 159 |
HYPOVOLAEMIC SHOCK |
4 |
0.0008 |
| 160 |
FACIAL BONES FRACTURE |
3 |
0.0008 |
| 161 |
LARGE INTESTINE INFECTION |
1 |
0.0008 |
| 162 |
BLOOD UREA DECREASED |
1 |
0.0008 |
| 163 |
AMMONIA INCREASED |
4 |
0.0008 |
| 164 |
PETECHIAE |
8 |
0.0008 |
| 165 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
2 |
0.0008 |
| 166 |
BODY MASS INDEX INCREASED |
1 |
0.0007 |
| 167 |
GLYCOSURIA |
1 |
0.0007 |
| 168 |
HYPERURICAEMIA |
3 |
0.0007 |
| 169 |
GENERALISED OEDEMA |
9 |
0.0007 |
| 170 |
HAIR GROWTH ABNORMAL |
5 |
0.0007 |
| 171 |
APPENDIX DISORDER |
1 |
0.0007 |
| 172 |
BLOOD ELECTROLYTES DECREASED |
1 |
0.0007 |
| 173 |
INTENSIVE CARE |
1 |
0.0007 |
| 174 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
1 |
0.0007 |
| 175 |
INJECTION SITE HYPOAESTHESIA |
1 |
0.0007 |
| 176 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
38 |
0.0007 |
| 177 |
ACUTE ABDOMEN |
1 |
0.0007 |
| 178 |
NORMOCYTIC ANAEMIA |
1 |
0.0007 |
| 179 |
CONJUNCTIVITIS ALLERGIC |
1 |
0.0007 |
| 180 |
MARASMUS |
1 |
0.0007 |
| 181 |
FUNGAEMIA |
1 |
0.0006 |
| 182 |
DRUG EFFECT INCREASED |
2 |
0.0006 |
| 183 |
LIVER ABSCESS |
2 |
0.0006 |
| 184 |
HEPATIC NEOPLASM |
2 |
0.0006 |
| 185 |
BODY TEMPERATURE DECREASED |
6 |
0.0006 |
| 186 |
PANCREATIC DISORDER |
3 |
0.0006 |
| 187 |
OXYGEN THERAPY |
1 |
0.0006 |
| 188 |
SYSTEMIC INFECTION |
1 |
0.0006 |
| 189 |
ARTHROPOD STING |
1 |
0.0006 |
| 190 |
SEIZURE LIKE PHENOMENA |
1 |
0.0006 |
| 191 |
FAILURE TO THRIVE |
3 |
0.0006 |
| 192 |
BRONCHIOLITIS |
2 |
0.0006 |
| 193 |
INDURATION |
1 |
0.0006 |
| 194 |
LOBAR PNEUMONIA |
1 |
0.0005 |
| 195 |
HYPERTHERMIA |
4 |
0.0005 |
| 196 |
BICYTOPENIA |
1 |
0.0005 |
| 197 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 198 |
LIPIDS INCREASED |
1 |
0.0005 |
| 199 |
VARICELLA ZOSTER VIRUS INFECTION |
1 |
0.0005 |
| 200 |
DILATATION VENTRICULAR |
1 |
0.0005 |
| 201 |
FOETAL DISTRESS SYNDROME |
1 |
0.0005 |
| 202 |
AMYOTROPHIC LATERAL SCLEROSIS |
1 |
0.0005 |
| 203 |
METASTATIC NEOPLASM |
2 |
0.0005 |
| 204 |
SUSPECTED OFF LABEL USE |
2 |
0.0004 |
| 205 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 206 |
VARICELLA |
1 |
0.0004 |
| 207 |
OXYGEN CONSUMPTION INCREASED |
1 |
0.0004 |
| 208 |
LONG QT SYNDROME |
1 |
0.0004 |
| 209 |
WRONG DOSE |
1 |
0.0004 |
| 210 |
BRONCHITIS CHRONIC |
1 |
0.0004 |
| 211 |
BLOOD PRESSURE DIASTOLIC DECREASED |
3 |
0.0004 |
| 212 |
SMALL FOR DATES BABY |
2 |
0.0004 |
| 213 |
INJECTION SITE ABSCESS |
1 |
0.0004 |
| 214 |
METASTASES TO LIVER |
7 |
0.0004 |
| 215 |
VASODILATATION |
1 |
0.0004 |
| 216 |
METASTASES TO PERITONEUM |
1 |
0.0004 |
| 217 |
DRUG TOLERANCE |
2 |
0.0004 |
| 218 |
HAEMATEMESIS |
10 |
0.0004 |
| 219 |
PHLEBITIS |
2 |
0.0004 |
| 220 |
LACTOSE INTOLERANCE |
1 |
0.0004 |
| 221 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0004 |
| 222 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
1 |
0.0004 |
| 223 |
BLOOD GLUCOSE ABNORMAL |
7 |
0.0004 |
| 224 |
THERAPY NON-RESPONDER |
17 |
0.0004 |
| 225 |
TRICUSPID VALVE INCOMPETENCE |
3 |
0.0004 |
| 226 |
TEMPOROMANDIBULAR JOINT SYNDROME |
1 |
0.0004 |
| 227 |
STEATORRHOEA |
1 |
0.0004 |
| 228 |
OEDEMA |
20 |
0.0004 |
| 229 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 230 |
POLYURIA |
3 |
0.0004 |
| 231 |
SKIN PLAQUE |
3 |
0.0004 |
| 232 |
BLOOD GLUCOSE DECREASED |
17 |
0.0004 |
| 233 |
PNEUMATOSIS INTESTINALIS |
1 |
0.0004 |
| 234 |
VASCULAR GRAFT |
1 |
0.0003 |
| 235 |
LUNG CANCER METASTATIC |
1 |
0.0003 |
| 236 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 237 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
3 |
0.0003 |
| 238 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 239 |
BLOOD TRIGLYCERIDES INCREASED |
6 |
0.0003 |
| 240 |
CREPITATIONS |
1 |
0.0003 |
| 241 |
BLOOD CULTURE POSITIVE |
1 |
0.0003 |
| 242 |
RESPIRATORY DISTRESS |
9 |
0.0003 |
| 243 |
PORTAL HYPERTENSION |
1 |
0.0003 |
| 244 |
SWELLING OF EYELID |
2 |
0.0003 |
| 245 |
ABDOMINAL ADHESIONS |
1 |
0.0003 |
| 246 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
3 |
0.0003 |
| 247 |
ORTHOPNOEA |
1 |
0.0003 |
| 248 |
ABSCESS |
5 |
0.0003 |
| 249 |
SUPRAVENTRICULAR TACHYCARDIA |
3 |
0.0003 |
| 250 |
EXPOSURE TO TOXIC AGENT |
1 |
0.0003 |
| 251 |
VENTRICULAR HYPOKINESIA |
1 |
0.0003 |
| 252 |
LYMPHOCYTE COUNT INCREASED |
1 |
0.0003 |
| 253 |
PEPTIC ULCER |
1 |
0.0003 |
| 254 |
EPILEPSY |
9 |
0.0003 |
| 255 |
ECCHYMOSIS |
2 |
0.0003 |
| 256 |
GRANULOMA |
1 |
0.0003 |
| 257 |
CAROTID ARTERY STENOSIS |
1 |
0.0003 |
| 258 |
PULMONARY TOXICITY |
2 |
0.0003 |
| 259 |
HEART DISEASE CONGENITAL |
1 |
0.0003 |
| 260 |
HAEMORRHAGIC DIATHESIS |
1 |
0.0003 |
| 261 |
PRODUCT SUPPLY ISSUE |
2 |
0.0003 |
| 262 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
2 |
0.0003 |
| 263 |
FLUID OVERLOAD |
4 |
0.0003 |
| 264 |
CARDIOMYOPATHY |
4 |
0.0003 |
| 265 |
HYPOPHOSPHATAEMIA |
2 |
0.0003 |
| 266 |
PARANASAL SINUS DISCOMFORT |
1 |
0.0003 |
| 267 |
HAEMODYNAMIC INSTABILITY |
2 |
0.0003 |
| 268 |
OESOPHAGEAL DISORDER |
1 |
0.0003 |
| 269 |
PERICARDIAL EFFUSION |
6 |
0.0003 |
| 270 |
LOW DENSITY LIPOPROTEIN INCREASED |
2 |
0.0003 |
| 271 |
OPTIC ISCHAEMIC NEUROPATHY |
1 |
0.0003 |
| 272 |
BLOOD PRESSURE SYSTOLIC INCREASED |
5 |
0.0003 |
| 273 |
PROCEDURAL HAEMORRHAGE |
1 |
0.0003 |
| 274 |
PULMONARY HAEMORRHAGE |
2 |
0.0003 |
| 275 |
RESPIRATORY ACIDOSIS |
1 |
0.0003 |
| 276 |
CREATININE RENAL CLEARANCE DECREASED |
1 |
0.0002 |
| 277 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 278 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 279 |
RECURRENT CANCER |
1 |
0.0002 |
| 280 |
SELF-MEDICATION |
1 |
0.0002 |
| 281 |
LEG AMPUTATION |
1 |
0.0002 |
| 282 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 283 |
ONYCHOMADESIS |
1 |
0.0002 |
| 284 |
ESCHERICHIA URINARY TRACT INFECTION |
1 |
0.0002 |
| 285 |
MULTI-ORGAN FAILURE |
4 |
0.0002 |
| 286 |
HEPATIC LESION |
1 |
0.0002 |
| 287 |
TUMOUR LYSIS SYNDROME |
2 |
0.0002 |
| 288 |
LIGAMENT RUPTURE |
1 |
0.0002 |
| 289 |
MALIGNANT NEOPLASM PROGRESSION |
23 |
0.0002 |
| 290 |
CARDIAC FAILURE |
18 |
0.0002 |
| 291 |
THIRST |
4 |
0.0002 |
| 292 |
TACHYPNOEA |
3 |
0.0002 |
| 293 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 294 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 295 |
YELLOW SKIN |
1 |
0.0002 |
| 296 |
TIBIA FRACTURE |
1 |
0.0002 |
| 297 |
HYPOCALCAEMIA |
4 |
0.0002 |
| 298 |
CARDIAC TAMPONADE |
1 |
0.0002 |
| 299 |
RECTAL HAEMORRHAGE |
9 |
0.0002 |
| 300 |
PULMONARY ARTERIAL HYPERTENSION |
3 |
0.0002 |
| 301 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 302 |
GASTROENTERITIS |
3 |
0.0002 |
| 303 |
OEDEMA PERIPHERAL |
25 |
0.0002 |
| 304 |
HEPATOMEGALY |
2 |
0.0002 |
| 305 |
INFLAMMATORY MARKER INCREASED |
1 |
0.0002 |
| 306 |
PNEUMONIA ASPIRATION |
5 |
0.0002 |
| 307 |
DERMATITIS EXFOLIATIVE |
1 |
0.0002 |
| 308 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 309 |
HYPOXIA |
7 |
0.0002 |
| 310 |
DYSLIPIDAEMIA |
1 |
0.0002 |
| 311 |
PANCYTOPENIA |
11 |
0.0002 |
| 312 |
FLUID RETENTION |
10 |
0.0002 |
| 313 |
HYPONATRAEMIA |
11 |
0.0002 |
| 314 |
FEMORAL NECK FRACTURE |
1 |
0.0002 |
| 315 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 316 |
CACHEXIA |
1 |
0.0002 |
| 317 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 318 |
RESPIRATORY FAILURE |
14 |
0.0002 |
| 319 |
MALABSORPTION |
1 |
0.0002 |
| 320 |
DRUG INTERACTION |
30 |
0.0002 |
| 321 |
METABOLIC ACIDOSIS |
6 |
0.0002 |
| 322 |
CARDIAC FAILURE CONGESTIVE |
15 |
0.0002 |
| 323 |
INTESTINAL RESECTION |
1 |
0.0002 |
| 324 |
PRODUCT PRESCRIBING ISSUE |
4 |
0.0002 |
| 325 |
HYDROCEPHALUS |
1 |
0.0002 |
| 326 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 327 |
VENTRICULAR FIBRILLATION |
2 |
0.0002 |
| 328 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 329 |
BLOOD UREA INCREASED |
3 |
0.0002 |
| 330 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 331 |
CIRCULATORY COLLAPSE |
3 |
0.0002 |
| 332 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 333 |
NEEDLE ISSUE |
5 |
0.0002 |
| 334 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 335 |
HYPERCHLORHYDRIA |
1 |
0.0002 |
| 336 |
TREATMENT FAILURE |
14 |
0.0002 |
| 337 |
HEPATIC FAILURE |
5 |
0.0002 |
| 338 |
INGUINAL HERNIA |
1 |
0.0002 |
| 339 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 340 |
NO THERAPEUTIC RESPONSE |
2 |
0.0002 |
| 341 |
RESPIRATORY DEPRESSION |
2 |
0.0002 |
| 342 |
CARDIOMEGALY |
2 |
0.0002 |
| 343 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 344 |
THROMBOCYTOPENIA |
18 |
0.0002 |
| 345 |
CHOLESTASIS |
3 |
0.0002 |
| 346 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 347 |
HAEMATOMA |
4 |
0.0002 |
| 348 |
CHOLELITHIASIS |
5 |
0.0002 |
| 349 |
SEPSIS |
17 |
0.0002 |
| 350 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 351 |
MENINGITIS |
1 |
0.0001 |
| 352 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 353 |
BODY TEMPERATURE INCREASED |
3 |
0.0001 |
| 354 |
ONYCHOCLASIS |
1 |
0.0001 |
| 355 |
WOUND |
4 |
0.0001 |
| 356 |
DUODENAL ULCER |
1 |
0.0001 |
| 357 |
METASTASIS |
1 |
0.0001 |
| 358 |
CONVULSION |
8 |
0.0001 |
| 359 |
MYELOSUPPRESSION |
5 |
0.0001 |
| 360 |
THERAPY CESSATION |
7 |
0.0001 |
| 361 |
SENSITIVE SKIN |
1 |
0.0001 |
| 362 |
MEDICAL DEVICE COMPLICATION |
1 |
0.0001 |
| 363 |
TACHYCARDIA |
12 |
0.0001 |
| 364 |
KETOACIDOSIS |
1 |
0.0001 |
| 365 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
0.0001 |
| 366 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 367 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 368 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 369 |
CONCUSSION |
1 |
0.0001 |
| 370 |
APHTHOUS ULCER |
1 |
0.0001 |
| 371 |
EJECTION FRACTION DECREASED |
2 |
0.0001 |
| 372 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 373 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 374 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0001 |
| 375 |
CYANOSIS |
2 |
0.0001 |
| 376 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 377 |
DRUG INTOLERANCE |
12 |
0.0001 |
| 378 |
RHINITIS |
1 |
0.0001 |
| 379 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 380 |
HYPERAESTHESIA |
1 |
0.0001 |
| 381 |
DRUG LEVEL INCREASED |
2 |
0.0001 |
| 382 |
BLOOD PRESSURE DECREASED |
8 |
0.0001 |
| 383 |
EPISTAXIS |
9 |
0.0001 |
| 384 |
CARDIO-RESPIRATORY ARREST |
5 |
0.0001 |
| 385 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
| 386 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
3 |
0.0001 |
| 387 |
FACE OEDEMA |
2 |
0.0001 |
| 388 |
NEUTROPENIA |
16 |
0.0001 |
| 389 |
PRODUCT USE IN UNAPPROVED INDICATION |
29 |
0.0001 |
| 390 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 391 |
MYOPATHY |
1 |
0.0001 |
| 392 |
MUSCLE STRAIN |
1 |
0.0001 |
| 393 |
PYELONEPHRITIS |
1 |
0.0001 |
| 394 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 395 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 396 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 397 |
PURPURA |
1 |
0.0001 |
| 398 |
DIABETES MELLITUS INADEQUATE CONTROL |
2 |
0.0001 |
| 399 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 400 |
CARDIOTOXICITY |
1 |
0.0001 |
| 401 |
DRY MOUTH |
9 |
0.0001 |
| 402 |
DEVELOPMENTAL DELAY |
1 |
0.0001 |
| 403 |
LEUKOCYTOSIS |
2 |
0.0001 |
| 404 |
OPTIC NEURITIS |
1 |
0.0001 |
| 405 |
HIDRADENITIS |
1 |
0.0001 |
| 406 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 407 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 408 |
UROSEPSIS |
1 |
0.0001 |
| 409 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 410 |
HYPOKALAEMIA |
5 |
0.0001 |
| 411 |
HEPATIC FUNCTION ABNORMAL |
4 |
0.0001 |
| 412 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 413 |
NEPHROPATHY |
1 |
0.0001 |
| 414 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 415 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 416 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 417 |
FRACTURE |
2 |
0.0001 |
| 418 |
ABDOMINAL DISTENSION |
11 |
0.0001 |
| 419 |
DIABETES MELLITUS |
8 |
0.0001 |
| 420 |
DRUG PRESCRIBING ERROR |
2 |
0.0001 |
| 421 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 422 |
ATELECTASIS |
1 |
0.0001 |
| 423 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 424 |
DRUG INEFFECTIVE |
134 |
0.0001 |
| 425 |
HYPOTHERMIA |
1 |
0.0001 |
| 426 |
TASTE DISORDER |
2 |
0.0001 |
| 427 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 428 |
NEUTROPHIL COUNT DECREASED |
4 |
0.0001 |
| 429 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 430 |
MOUTH ULCERATION |
2 |
0.0001 |
| 431 |
RENAL PAIN |
1 |
0.0001 |
| 432 |
HYPOTHYROIDISM |
3 |
0.0001 |
| 433 |
EATING DISORDER |
2 |
0.0001 |
| 434 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 435 |
DISEASE PROGRESSION |
11 |
0.0001 |
| 436 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 437 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 438 |
TREATMENT NONCOMPLIANCE |
5 |
0.0001 |
| 439 |
ASPIRATION |
1 |
0.0001 |
| 440 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 441 |
RENAL FAILURE |
12 |
0.0001 |
| 442 |
FOOT DEFORMITY |
1 |
0.0001 |
| 443 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 444 |
MALNUTRITION |
1 |
0.0001 |
| 445 |
PULMONARY OEDEMA |
4 |
0.0001 |
| 446 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 447 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 448 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 449 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 450 |
DRUG EXPOSURE DURING PREGNANCY |
3 |
0.0001 |
| 451 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 452 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 453 |
NEOPLASM |
1 |
0.0001 |
| 454 |
METASTASES TO LUNG |
1 |
0.0001 |
| 455 |
CAESAREAN SECTION |
1 |
0.0001 |
| 456 |
PLATELET COUNT DECREASED |
9 |
0.0001 |
| 457 |
DISEASE RECURRENCE |
4 |
0.0001 |
| 458 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 459 |
ELECTROCARDIOGRAM QT PROLONGED |
3 |
0.0001 |
| 460 |
OFF LABEL USE |
73 |
0.0001 |
| 461 |
RENAL IMPAIRMENT |
7 |
0.0001 |
| 462 |
DRUG EFFECT INCOMPLETE |
3 |
0.0001 |
| 463 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 464 |
SCHIZOPHRENIA |
1 |
0.0001 |
| 465 |
CYTOPENIA |
1 |
0.0001 |
| 466 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 467 |
PHARYNGITIS |
1 |
0.0001 |
| 468 |
ILEUS |
1 |
0.0001 |
| 469 |
WEIGHT INCREASED |
18 |
0.0001 |
| 470 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 471 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
2 |
0.0001 |
| 472 |
ANOREXIA |
1 |
0.0001 |
| 473 |
HIATUS HERNIA |
1 |
0.0001 |
| 474 |
BEDRIDDEN |
1 |
0.0001 |
| 475 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 476 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 477 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 478 |
ABNORMAL BEHAVIOUR |
3 |
0.0001 |
| 479 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 480 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 481 |
PRODUCT TASTE ABNORMAL |
1 |
0.0001 |
| 482 |
PNEUMONITIS |
2 |
0.0001 |
| 483 |
DRUG TOXICITY |
1 |
0.0001 |
| 484 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 485 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 486 |
LETHARGY |
4 |
0.0001 |
| 487 |
SEIZURE |
8 |
0.0001 |
| 488 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 489 |
ASCITES |
2 |
0.0001 |
| 490 |
BRONCHITIS |
5 |
0.0001 |
| 491 |
GASTROINTESTINAL DISORDER |
6 |
0.0001 |
| 492 |
IRRITABILITY |
4 |
0.0001 |
| 493 |
OSTEOPENIA |
1 |
0.0001 |
| 494 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 495 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 496 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 497 |
FEMUR FRACTURE |
2 |
0.0001 |
| 498 |
BRAIN FOG |
1 |
0.0001 |
| 499 |
PNEUMOTHORAX |
1 |
0.0001 |
| 500 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 501 |
ULCER |
1 |
0.0001 |
| 502 |
OBESITY |
1 |
0.0001 |
| 503 |
CONDITION AGGRAVATED |
19 |
0.0001 |
| 504 |
HIP FRACTURE |
2 |
0.0001 |
| 505 |
METASTASES TO BONE |
1 |
0.0001 |
| 506 |
EYE DISORDER |
2 |
0.0001 |
| 507 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 508 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 509 |
FEBRILE NEUTROPENIA |
4 |
0.0001 |
| 510 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 511 |
PERICARDITIS |
1 |
0.0001 |
| 512 |
PRODUCT USE ISSUE |
11 |
0.0001 |
| 513 |
HAEMATURIA |
2 |
0.0001 |
| 514 |
BLOOD GLUCOSE INCREASED |
11 |
0.0001 |
| 515 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 516 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 517 |
ANAEMIA |
11 |
0.0001 |
| 518 |
LOCAL SWELLING |
1 |
0.0001 |
| 519 |
RASH MACULAR |
2 |
0.0001 |
| 520 |
INTENTIONAL PRODUCT MISUSE |
5 |
0.0001 |
| 521 |
BRADYCARDIA |
3 |
0.0001 |
| 522 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 523 |
BONE DISORDER |
1 |
0.0001 |
| 524 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 525 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 526 |
DYSGEUSIA |
4 |
0.0001 |
| 527 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 528 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 529 |
GASTRIC ULCER |
1 |
0.0001 |
| 530 |
DEHYDRATION |
7 |
0.0001 |
| 531 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 532 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 533 |
CHOKING |
1 |
0.0001 |
| 534 |
SKIN FISSURES |
1 |
0.0001 |
| 535 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 536 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 537 |
WEIGHT DECREASED |
14 |
0.0001 |
| 538 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 539 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 540 |
STOMATITIS |
3 |
0.0000 |
| 541 |
PNEUMONIA |
16 |
0.0000 |
| 542 |
VERTIGO |
3 |
0.0000 |
| 543 |
ALANINE AMINOTRANSFERASE INCREASED |
3 |
0.0000 |
| 544 |
RIB FRACTURE |
1 |
0.0000 |
| 545 |
INFECTION |
7 |
0.0000 |
| 546 |
INTENTIONAL DRUG MISUSE |
1 |
0.0000 |
| 547 |
DERMATITIS |
1 |
0.0000 |
| 548 |
RENAL FAILURE ACUTE |
2 |
0.0000 |
| 549 |
RHINORRHOEA |
3 |
0.0000 |
| 550 |
BALANCE DISORDER |
4 |
0.0000 |
| 551 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 552 |
SEPTIC SHOCK |
2 |
0.0000 |
| 553 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 554 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 555 |
MELAENA |
1 |
0.0000 |
| 556 |
LIVER DISORDER |
2 |
0.0000 |
| 557 |
HYPOTENSION |
9 |
0.0000 |
| 558 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 559 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 560 |
SHOCK |
1 |
0.0000 |
| 561 |
GENERAL PHYSICAL HEALTH DETERIORATION |
5 |
0.0000 |
| 562 |
CHILLS |
5 |
0.0000 |
| 563 |
VOMITING |
20 |
0.0000 |
| 564 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 565 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 566 |
HEPATIC CANCER |
1 |
0.0000 |
| 567 |
PRESYNCOPE |
1 |
0.0000 |
| 568 |
URINARY TRACT INFECTION |
7 |
0.0000 |
| 569 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 570 |
CELLULITIS |
2 |
0.0000 |
| 571 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 572 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 573 |
HEPATITIS |
1 |
0.0000 |
| 574 |
FALL |
13 |
0.0000 |
| 575 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 576 |
HAEMOGLOBIN DECREASED |
4 |
0.0000 |
| 577 |
DRUG RESISTANCE |
1 |
0.0000 |
| 578 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 579 |
RASH GENERALISED |
1 |
0.0000 |
| 580 |
DIPLOPIA |
1 |
0.0000 |
| 581 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 582 |
ARTHRITIS |
3 |
0.0000 |
| 583 |
GASTRITIS |
1 |
0.0000 |
| 584 |
PANCREATITIS |
2 |
0.0000 |
| 585 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 586 |
EAR INFECTION |
1 |
0.0000 |
| 587 |
PYREXIA |
13 |
0.0000 |
| 588 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 589 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 590 |
LIMB INJURY |
1 |
0.0000 |
| 591 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 592 |
TREMOR |
6 |
0.0000 |
| 593 |
DIZZINESS |
18 |
0.0000 |
| 594 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 595 |
MEDICATION ERROR |
2 |
0.0000 |
| 596 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 597 |
INFLUENZA |
4 |
0.0000 |
| 598 |
ALOPECIA |
7 |
0.0000 |
| 599 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 600 |
FLATULENCE |
2 |
0.0000 |
| 601 |
HYPERSOMNIA |
1 |
0.0000 |
| 602 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 603 |
DECREASED APPETITE |
8 |
0.0000 |
| 604 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 605 |
BONE PAIN |
2 |
0.0000 |
| 606 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 607 |
PREMATURE BABY |
1 |
0.0000 |
| 608 |
JOINT SWELLING |
4 |
0.0000 |
| 609 |
HYPERTENSION |
7 |
0.0000 |
| 610 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 611 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 612 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 613 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 614 |
DYSPHAGIA |
3 |
0.0000 |
| 615 |
HEAD INJURY |
1 |
0.0000 |
| 616 |
GAIT DISTURBANCE |
6 |
0.0000 |
| 617 |
HYPERHIDROSIS |
4 |
0.0000 |
| 618 |
NIGHT SWEATS |
1 |
0.0000 |
| 619 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 620 |
SWELLING FACE |
2 |
0.0000 |
| 621 |
PRODUCT DOSE OMISSION |
2 |
0.0000 |
| 622 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 623 |
DYSPEPSIA |
3 |
0.0000 |
| 624 |
OSTEONECROSIS |
1 |
0.0000 |
| 625 |
HEART RATE INCREASED |
3 |
0.0000 |
| 626 |
VIRAL INFECTION |
1 |
0.0000 |
| 627 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 628 |
GAIT INABILITY |
1 |
0.0000 |
| 629 |
FLUSHING |
3 |
0.0000 |
| 630 |
ASTHENIA |
11 |
0.0000 |
| 631 |
ABDOMINAL PAIN UPPER |
6 |
0.0000 |
| 632 |
GASTRIC DISORDER |
1 |
0.0000 |
| 633 |
VISION BLURRED |
4 |
0.0000 |
| 634 |
NAUSEA |
23 |
0.0000 |
| 635 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 636 |
HYPERKALAEMIA |
1 |
0.0000 |
| 637 |
HEART RATE DECREASED |
1 |
0.0000 |
| 638 |
SLEEP DISORDER |
2 |
0.0000 |
| 639 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 640 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 641 |
CRYING |
1 |
0.0000 |
| 642 |
DYSARTHRIA |
1 |
0.0000 |
| 643 |
DYSPNOEA |
15 |
0.0000 |
| 644 |
ACNE |
2 |
0.0000 |
| 645 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 646 |
INJECTION SITE PAIN |
8 |
0.0000 |
| 647 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 648 |
BACK PAIN |
6 |
0.0000 |
| 649 |
ABDOMINAL PAIN |
6 |
0.0000 |
| 650 |
DEATH |
22 |
0.0000 |
| 651 |
FEELING ABNORMAL |
6 |
0.0000 |
| 652 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 653 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 654 |
DYSKINESIA |
1 |
0.0000 |
| 655 |
OSTEOPOROSIS |
1 |
0.0000 |
| 656 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 657 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 658 |
DIARRHOEA |
15 |
0.0000 |
| 659 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 660 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 661 |
COVID-19 |
4 |
0.0000 |
| 662 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 663 |
THROAT IRRITATION |
1 |
0.0000 |
| 664 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 665 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 666 |
ADVERSE EVENT |
2 |
0.0000 |
| 667 |
NASOPHARYNGITIS |
4 |
0.0000 |
| 668 |
COUGH |
6 |
0.0000 |
| 669 |
ARRHYTHMIA |
1 |
0.0000 |
| 670 |
COMA |
1 |
0.0000 |
| 671 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 672 |
CONTUSION |
2 |
0.0000 |
| 673 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 674 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 675 |
LEUKOPENIA |
1 |
0.0000 |
| 676 |
SOMNOLENCE |
4 |
0.0000 |
| 677 |
SINUSITIS |
2 |
0.0000 |
| 678 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 679 |
ILLNESS |
2 |
0.0000 |
| 680 |
INFLAMMATION |
1 |
0.0000 |
| 681 |
NERVOUSNESS |
1 |
0.0000 |
| 682 |
ECZEMA |
1 |
0.0000 |
| 683 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 684 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 685 |
OVERDOSE |
4 |
0.0000 |
| 686 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 687 |
NECK PAIN |
1 |
0.0000 |
| 688 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 689 |
DYSPHONIA |
1 |
0.0000 |
| 690 |
PALPITATIONS |
2 |
0.0000 |
| 691 |
NASAL CONGESTION |
1 |
0.0000 |
| 692 |
WHEEZING |
1 |
0.0000 |
| 693 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 694 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 695 |
DISCOMFORT |
1 |
0.0000 |
| 696 |
MUSCLE SPASMS |
3 |
0.0000 |
| 697 |
FEELING HOT |
1 |
0.0000 |
| 698 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 699 |
RASH |
7 |
0.0000 |
| 700 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 701 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 702 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 703 |
ERYTHEMA |
3 |
0.0000 |
| 704 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 705 |
HEADACHE |
9 |
0.0000 |
| 706 |
BURNING SENSATION |
1 |
0.0000 |
| 707 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 708 |
FATIGUE |
11 |
0.0000 |
| 709 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 710 |
ANXIETY |
4 |
0.0000 |
| 711 |
HALLUCINATION |
1 |
0.0000 |
| 712 |
HOT FLUSH |
1 |
0.0000 |
| 713 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 714 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 715 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 716 |
PAIN |
8 |
0.0000 |
| 717 |
HOSPITALISATION |
2 |
0.0000 |
| 718 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 719 |
PROSTATE CANCER |
1 |
0.0000 |
| 720 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 721 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 722 |
CARDIAC ARREST |
1 |
0.0000 |
| 723 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 724 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 725 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 726 |
MYALGIA |
2 |
0.0000 |
| 727 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 728 |
INSOMNIA |
3 |
0.0000 |
| 729 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 730 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 731 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 732 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 733 |
CHEST PAIN |
2 |
0.0000 |
| 734 |
CARDIAC DISORDER |
1 |
0.0000 |
| 735 |
SWELLING |
1 |
0.0000 |
| 736 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 737 |
SYNCOPE |
1 |
0.0000 |
| 738 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 739 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 740 |
ARTHRALGIA |
4 |
0.0000 |
| 741 |
CONSTIPATION |
2 |
0.0000 |
| 742 |
ASTHMA |
1 |
0.0000 |
| 743 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 744 |
DEPRESSION |
2 |
0.0000 |
| 745 |
PRURITUS |
3 |
0.0000 |
| 746 |
DRY SKIN |
1 |
0.0000 |
| 747 |
MALAISE |
3 |
0.0000 |
| 748 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 749 |
HYPOAESTHESIA |
1 |
0.0000 |
| 750 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 751 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 752 |
URTICARIA |
1 |
0.0000 |
| 753 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 754 |
HYPERSENSITIVITY |
1 |
0.0000 |